Analysis of Aseptic Sampling market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global aseptic sampling market is predicted to expand at an impressive CAGR of 11% and increase from a market valuation of US$ 388.1 million in 2022 to US$ 654 million by the end of 2027.
Global sales of manual aseptic sampling systems are expected to rise faster at a CAGR of 12% from 2022 to 2027; this can be attributed to the high demand from pharmaceutical and biopharmaceutical companies.
Aseptic Sampling Market Size (2022E)
US$ 388.1 Million
Forecasted Market Value (2027F)
US$ 654 Million
Global Market Growth Rate (2022-2027)
China Market Value (2027F)
US$ 143 Million
Key Companies Profiled
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Aseptic sampling is a sterile technique for collecting samples that guard against contamination while being taken. Aseptic samples are used to verify some procedures and to back up some process-related observations. This procedure is used to guarantee product safety and to get rid of product contamination.
Using an aseptic sampling valve and bags is typically a part of aseptic sampling. A successful microbial control program must include this procedure. Manual aseptic sampling and automatic aseptic sampling are the two types of aseptic sampling equipment.
The worldwide aseptic sampling market is anticipated to develop over the projected period as more pharmaceutical and biopharmaceutical businesses employ aseptic sampling to lower the risk of product contamination. Furthermore, it is also anticipated that rising government activities of respective nations to guarantee product quality and safety will support market expansion.
According to the recent market study on aseptic sampling by Fact.MR, a market research and competitive intelligence provider, global sales of aseptic sampling devices are expected to surge at a CAGR of 11% and reach US$ 654 million by 2027.
“High Demand for Aseptic Sampling Techniques from Biotechnology & Pharmaceutical Industries to Reduce Contamination Risk”
Due to rising R&D investments and a growing pipeline of biological and pharmaceutical products, biotechnology and pharmaceutical producers are anticipated to experience significant growth in the aseptic sampling market.
Growth in the market is also anticipated to be fuelled by improvements in innovation strategies and their adoption by pharmaceutical and biotechnological firms.
Additionally, due to the COVID-19 crisis, the majority of the nations in Europe and Asia have dramatically increased their production of essential medicines.
One of the main drivers of market expansion is acquisition.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Use of Plastic Polymers in Production of Aseptic Sampling Products Hindering Market Growth”
Some limitations and difficulties will prevent the market from expanding. Products for aseptic sampling are made of processed plastic polymers, which can leach and extract from solvents, thereby contaminating samples.
Leachability and extractability problems with single-use items are significant factors impeding the growth of the global aseptic sampling market. However, several biopharmaceutical processes usually call for high temperatures to function, which causes the production of superfluous and unidentified compounds that could contaminate the final product. Thus, this is another significant obstacle limiting the usage of single-use bioprocessing devices.
“Presence of Strong Pharmaceutical Companies in North America Driving Sales of Aseptic Sampling Devices”
During the projection period, North America is anticipated to maintain its significant market share in aseptic sampling. The North America aseptic sampling market will be driven by the established pharma sector, an increase in product launches and expansions by major industry participants, and strict respective government regulations regarding the safety and quality of various pharmaceuticals.
Major firms in the region have started several different methods to hold onto market share and develop into newer product categories.
Due to a surge in aseptic sampling demand, strict governmental regulations, and greater innovation efforts, Europe made up a sizeable portion of the worldwide aseptic sampling market.
During the projected period the Asia Pacific market is predicted to expand at a significant CAGR. The aseptic sampling market in the Asia Pacific region is anticipated to grow as a result of increased investments by many important regional companies, improvements in the region's healthcare infrastructure, and favourable regulatory reforms.
Due to an increase in market participants' investments in Latin America, the Middle East, and Africa, it is predicted that these regions' markets would develop throughout the projection period.
“Top Companies Focusing on R&D of Aseptic Sampling Equipment to Increase their Market Share”
The United States dominates the North America aseptic sampling market. Due to the existence of major market participants and growing government support for the development and quality of pharmaceutical and biotechnology products, the United States is anticipated to have a sizeable proportion of the market.
Companies have been participating in partnerships, mergers, and acquisitions to expand their product lines, production capabilities, and competitive differentiation.
The United States Food and Drug Administration estimates that there were roughly 53 new medications authorised in 2020 as opposed to 48 in 2019. Furthermore, 12 more new medications were approved in the United States by March 2021.
The U.S. aseptic sampling market is expected to increase throughout the forecast period due to factors such as the rise in healthcare spending, government regulations to assure drug safety, and an increase in R&D activities in the sector.
“Significant Demand for Aseptic Sampling Systems from Pharmaceutical CMO Industry for Infection-free Medicine Processing”
The Indian pharmaceutical contract manufacturing sector would have an upward trend due to the increase in demand for injection medications, particularly in cancer research, thus for effective containment-free medicine processing results advanced aseptic sampling techniques are required.
Compared to other sampling types, manual sampling is highly preferred due to its effective results. The country's aseptic sampling sector is thus anticipated to increase as a result of a higher success rate and therapeutic efficacy.
India has made a significant transition from pharmaceutical production to contract manufacturing during the last few decades.
Thus, the growing pharmaceutical CMO industry supports sales of aseptic sampling systems.
“High Demand for Manual Aseptic Sampling Systems Due to Their Effective Aseptic Technique, Design, & Less Cost”
Aseptic sampling is a way for preventing contamination during the sampling procedure. The use of sterile sampling tools and containers is vital for aseptic sampling.
The use of the 'Sterility By Design' approach, which selects the design and controls needs for success to reduce the risk of contamination, is considered the best practice in aseptic processing.
Over the past decades, commercial aseptic processing has seen significant change. The negative effects of the operator have been significantly reduced by technical advancements, particularly in the areas of automation (which requires less operator intervention) and separation (the operator has moved farther away from sterile items). However, the operator frequently takes center stage in aseptic procedures where sterile objects are handled.
When done correctly using proper aseptic techniques and adhering to the design principles, manual aseptic sampling processes are typically regarded as safe. It is anticipated that there would be a rise in the adoption of closed systems (either single-use or isolators).
When compared to manual aseptic sampling, automated aseptic sampling from bioreactors offers better aseptic handling, lowers error, and boosts reproducibility. But due to the widespread use of manual sampling and the high cost of automated aseptic sampling devices, manual aseptic sampling systems are expected to grow at a high rate over the projected period and currently lead the aseptic sampling market.
Global sales of manual aseptic sampling systems are expected to rise at a high CAGR of 12% and reach US$ 381 million by 2027.
The industries with the highest consumption rates of aseptic sampling are biotechnology and pharmaceutical. Aseptic sampling techniques are currently being adopted by both new and existing production facilities, and demand for aseptic sampling technologies is increasing due to the low investment cost and simple execution.
Top companies in the aseptic sampling market are Merck KGaA, Sartorius Stedim Biotech, Saint Gobain, GEA Group, Keofitt, Thermo Fisher Scientific, and Danaher Corporation. Technological advancements in product development will open up new opportunities for manufacturers in the aseptic sampling market.
Developments in the Aseptic Sampling Market
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
The global aseptic sampling market is estimated to rise at a CAGR of 11% from 2022 to 2027.
The market for aseptic sampling devices and systems is currently valued at US$ 388.1 million.
Sartorius Stedim Biotech, Merck Millipore, Danaher Corporation, Thermo Fisher Scientific, Saint-Gobain, GEA Group, and Avantor Inc. are some of the key aseptic sampling providers.
By 2027, the global aseptic sampling market is anticipated to reach US$ 654 million.
Global demand for manual aseptic sampling is predicted to increase at 12% CAGR over the next 5 years.
Need An Exclusive Report For Your Unique Requirement?